SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Annual Wellness Visit, Subsequent — Hubert H. Humphrey

PatientHubert H. Humphrey
Date of birth1960-05-27
IdentifiersMRN HR-ML022-SYN; SSN (made up) 000-22-8047
Document date2026-06-02
AuthorWalter Brandvold, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Subsequent annual wellness visit; no new complaints. [S]

History of Present Illness

Mr. Humphrey is a 66-year-old man with bladder cancer treated by radical cystoprostatectomy with an ileal conduit eight months ago, who returns for his subsequent annual wellness visit; his initial wellness visit was a year ago. He completed the health risk assessment beforehand. Since his last visit he has felt well. He takes sodium bicarbonate twice a day and his tiredness has improved. He drinks about 2 liters a day. The appliance seals well and he changes it every four days. He walks 30 minutes most days and works full time. The kidney infection in March cleared within two days of starting ciprofloxacin, with no recurrence. He has had no falls, emergency visits, or hospital stays since his operation. [S]

ElementDetail
VisitSubsequent annual wellness visit
Safety eventsNo falls, emergency visits, or hospital stays since his operation
MedicinesSodium bicarbonate 650 mg twice daily; no other prescription or over-the-counter medicines
Active conditionsBladder cancer after radical cystoprostatectomy, no evidence of disease; ileal conduit; mild metabolic acidosis on treatment
Functional statusIndependent in all activities and instrumental activities of daily living, including stoma care

Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]

DomainFinding
Self-rated healthGood, and better than three months ago
PsychosocialBusy and engaged at work; close family and many friends; no loneliness or low mood
TobaccoNo current tobacco use; past tobacco history not recorded
Alcohol and drugsAn occasional drink at social events (AUDIT-C 2); no other drug use
Physical activityWalks 30 minutes most days
NutritionRegular meals, often late; about 2 liters of fluid a day
SleepSix to seven hours a night; a night drainage bag means he no longer wakes to empty the appliance
Activities of daily livingIndependent
Instrumental activities of daily livingIndependent; orders his own stoma supplies; drives
Home safetySmoke detectors working; no stairs without rails
FallsNo falls this year; no fear of falling
Hearing and visionNo hearing concern; reading glasses; eye examination last year
MemoryNo concerns
Sexual healthErectile function has not returned since the cystoprostatectomy; he has discussed options with urology and does not want treatment now

Review of Systems

SystemResultFinding
ConstitutionalNegativeEnergy better; weight up; no fever or night sweats
EyesNegativeNo change in vision
Ears, nose, mouth, and throatNegativeNo hearing loss
CardiovascularNegativeNo chest pain, palpitations, or leg swelling
RespiratoryNegativeNo cough, breathlessness, or hemoptysis
GastrointestinalNegativeBowels regular; no bleeding or abdominal pain
GenitourinaryPositiveClear urine from the conduit; no flank pain; erectile dysfunction since surgery
MusculoskeletalNegativeNo bone or back pain
IntegumentaryNegativePeristomal skin intact; no new skin lesions
NeurologicalNegativeNo headache, weakness, or numbness
PsychiatricNegativeMood good; PHQ-2 score 0
Hematologic and lymphaticNegativeNo easy bruising or enlarged glands

12 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Sodium bicarbonate 650 mg oral tablet, one tablet by mouth twice daily, for metabolic acidosis after an ileal conduitOne tablet twice dailyOral route2026-04-07activeS
Ciprofloxacin 500 mg oral tablet, one tablet by mouth twice daily for 7 days, for acute pyelonephritisOne tablet twice daily for 7 daysOral route2026-03-17 to 2026-03-23completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-06-02Body height180cmS
2026-06-02Body weight78.4kgS
2026-06-02Body mass index (BMI) [Ratio]24.2kg/m2S
2026-06-02Systolic blood pressure128mm[Hg]S
2026-06-02Diastolic blood pressure76mm[Hg]S
2026-06-02Heart rate70/minS
2026-06-02Respiratory rate14/minS
2026-06-02Body temperature36.6CelS
2026-06-02Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-06-02Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
2026-06-02Total score [Mini-Cog]5{score}S
2026-06-02Total score [AUDIT-C]2{score}S
2026-06-02Cholesterol [Mass/volume] in Serum or Plasma196mg/dL<=200 mg/dLNormalS
2026-06-02Cholesterol in HDL [Mass/volume] in Serum or Plasma46mg/dL>=40 mg/dLNormalS
2026-06-02Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation124mg/dL<=129 mg/dLNormalS
2026-06-02Triglyceride [Mass/volume] in Serum or Plasma130mg/dL<=149 mg/dLNormalS

Physical Exam

Vital signs recorded on 2026-06-02; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell and energetic; weight 78.4 kg, BMI 24.2
EyesPupils equal and reactive; near vision 20/30 with reading glasses
EarsWhispered-voice test passed in both ears
NeckNo lymph nodes
CardiovascularRegular rhythm at 70 per minute; no murmur; no edema
RespiratoryClear to auscultation bilaterally
AbdomenSoft and non-tender; healed midline incision; no incisional or parastomal hernia
StomaPink and moist; peristomal skin intact; appliance well fitted
Lymph nodesNo inguinal or supraclavicular nodes
MusculoskeletalTimed Up and Go 8 seconds
NeurologicalAlert and oriented; gait steady; Mini-Cog 5 of 5
PsychiatricEuthymic, animated, and engaged
SkinNo suspicious lesions

Problems

ProblemClinical statusVerificationCodeProvenance
Urothelial carcinoma of the bladder, multifocal, with carcinoma in situ, pT2a pN0 (0 of 18 nodes), margins negative, treated by radical cystoprostatectomy with an ileal conduit; no evidence of disease; under surveillance; synthetic modern detail linked to his documented bladder canceractiveconfirmed Z85.51S — Synthetic grade, stage, node count, and margins; the bladder growths, the earlier thiotepa and X-ray therapy, the low-grade malignancy, and the radical cystectomy with a small-intestine conduit are documented (D). Z85.51 is used because the tumor has been removed and no further treatment is directed at it.
Ileal conduit urostomy, right lower abdomenactiveconfirmed Z93.6S — The small-intestine conduit and the stoma to the right of the navel are documented (D); the coding and the stoma findings are synthetic.
Acquired absence of the bladder and part of the urethra after radical cystectomyactiveconfirmed Z90.6S — Documented operation (D); synthetic coding.
Acquired absence of the prostate after cystoprostatectomyactiveconfirmed Z90.79S — Documented operation (D); synthetic coding.
Personal history of pelvic radiation for bladder tumor, with earlier intravesical thiotepaactiveconfirmed Z92.3S — The thiotepa and X-ray therapy are documented (D); the coding and their relevance to the modern episode are synthetic.
Hyperchloremic metabolic acidosis from the ileal conduit, mildactiveconfirmed E87.22S — Synthetic finding at the six-month visit, a known effect of urine contact with the ileal segment.
Acute right pyelonephritis with an ileal conduit (Escherichia coli), with mild acute kidney injury, treated with oral ciprofloxacin and resolvedresolvedconfirmed N10S — Synthetic intercurrent infection at an unscheduled visit, a common complication of an ileal conduit; it does not echo a documented illness of his after the operation.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Pneumococcal vaccineCompleted todayPCV20 given today; no earlier pneumococcal vaccine on record; no further doses needed
Recombinant zoster vaccineCompleted todayDose 1 given today; dose 2 due in two to six months
Influenza vaccineDueHigh-dose vaccine in the autumn
COVID-19 vaccineDueThis season's vaccine in the autumn
RSV vaccineNot indicatedRecommended at 75 and older, or at 50 to 74 with increased risk; no qualifying condition now
Tetanus, diphtheria, and pertussis boosterUp to dateTdap six years ago; next dose due in four years
Colorectal cancer screeningUp to dateColonoscopy four years ago was normal; next due in six years. Report rectal bleeding at any time, given the earlier pelvic radiation
Prostate cancer screeningNot indicatedProstate removed at cystoprostatectomy
Lung cancer and abdominal aortic aneurysm screeningDueEligibility depends on lifetime smoking history, which is not recorded in this record; the history is to be taken at the next visit and screening offered if he qualifies
Cholesterol and statin decisionCompleted todayTotal cholesterol 196, HDL 46, LDL 124 mg/dL; no diabetes; blood pressure 128/76 mm Hg untreated; ten-year risk about 14 percent as a current non-smoker. No additional USPSTF risk factor is recorded, so this is a shared decision; he chose to revisit it next year
Hepatitis C screeningUp to dateOne-time antibody screen negative before his operation
Diabetes screeningNot indicatedBMI 24.2, below the overweight threshold for screening
Depression screeningCompleted todayPHQ-2 score 0
Unhealthy alcohol use screeningCompleted todayAUDIT-C score 2, low risk
Cognitive assessmentCompleted todayMini-Cog 5 of 5
Falls preventionCompleted todayTimed Up and Go 8 seconds; no falls
HearingCompleted todayWhispered-voice test passed in both ears

Immunizations given today: Pneumococcal conjugate vaccine PCV20; Recombinant zoster vaccine, dose 1 of 2 [S]

Guideline basis: CMID: Clinical Monitoring Intelligence Database, urologic cancer monograph (2026); Medicare Wellness Visits (Medicare Learning Network) (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)

Follow-up: Chronic-care follow-up in five weeks with chemistry. CT at one year after surgery. Second zoster dose in two to six months. Next annual wellness visit in one year. Next scheduled visit 2026-07-07: nine-month post-cystectomy follow-up: acid-base on bicarbonate, stoma review, and the surveillance schedule. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 20 minutes, with his consent. He named a health care agent, and a health care proxy form was completed; the agent is recorded in the chart and is not named here. He said that what matters most to him is being able to keep working and to be with the people he cares about, and that he wants to be told plainly about his results. He chose not to record specific treatment preferences today. The plan will be revisited yearly and with any change in his health. [S]